Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c8dbaf6696973727e49c5f56fc0ed09 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
filingDate |
2003-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d7bdaf04a9493bf267926a9583fc2d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbb5b1b9ddb08bd8e59f99aea25bb6d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b725d28a2862514d00ead084620cbf |
publicationDate |
2007-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7232800-B2 |
titleOfInvention |
Derivatives of magainin and methods of production thereof |
abstract |
The present invention provides a Magainin derivative peptide and method of production thereof. Also provided is a pharmaceutically composition comprising said Magainin derivative peptide and pharmaceutically acceptable carrier and/or pharmaceutically compatible binding agents. The Magainin derivative peptide of the present invention having amino acid sequence of the general formula shown as below: n n n n n n n Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys- n n n Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-X-Asn-Y-Z-OH n n n n n n n n n n in which: X is an amino acid residue selected from the group consisting of Met, Ile and Leu; Y is an amino acid residue selected from the group consisting of Ser, Lys, Ile, Arg and Leu; and Z is Arg. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006264364-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7550426-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101182360-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10470459-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007166790-A1 |
priorityDate |
2001-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |